Introduction Despite the considerable overlap of asthma and chronic obstructive pulmonary disease (COPD), the extent to which the two diagnoses are the manifestations of the same disease remains unresolved. We conducted these analyses to evaluate the role of active asthma in the prevalence of physician-diagnosed COPD. Methods From 2006 through 2010, 74,209 adults aged 18-99 years and with a history of asthma participated in the Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-back Survey and responded to interviewadministered questionnaires via telephone. We used publicly available data from 71,639 (97%) participants to identify respondents with and without active manifestations of asthma and self-reported, physician-diagnosed COPD. We generated population-weighted estimates of physiciandiagnosed COPD prevalence and conducted linear regression to estimate associations between active asthma status and the prevalence of COPD among current smokers, former smokers, and lifetime nonsmokers separately. Results Physician-diagnosed COPD was reported in an estimated 29% of the population with any history of asthma, including both active and inactive asthma. Agespecific prevalences of physician-diagnosed COPD were consistently higher among adults with active asthma than adults without active asthma. Compared to inactive asthma, active asthma was associated with an 8.3% [95 % confidence interval (CI) 6.1, 10.5] higher prevalence of physician-diagnosed COPD among lifetime nonsmokers, a 20.6% (95 % CI 18.0, 23.3) higher prevalence among former smokers, and a 26.7% (95 % CI 22.5, 30.9) higher prevalence among current smokers. Conclusions Among adults with a history of asthma, active manifestations of asthma may play an important role in the epidemiology of COPD.
Introduction
Asthma and chronic obstructive pulmonary disease (COPD) are common respiratory health conditions. Recent estimates in the United States indicate that in 2010, 11% of children 5-14 years of age, 9% of individuals 15-34 years of age, and 8% of adults aged 35 and older experienced current asthma [1] . The same year, nearly 6% of adults aged 25 years and older reported physician-diagnosed COPD, with the percentages increasing to 10% among adults 65 years and older [2] . The co-occurrence of asthma and COPD diagnoses, often referred to as 'overlap syndrome,' is well described, especially at older ages [3] [4] [5] [6] [7] [8] .
Despite the substantial overlap, the extent to which the two diagnoses are manifestations of the same disease or distinct entities remains unresolved [4, 6, 7, [9] [10] [11] [12] [13] [14] [15] . Asthma affects individuals at younger ages, whereas COPD occurs at older ages [1, 2] . Asthma is associated with eosinophilic inflammation, whereas COPD is associated with neutrophilic inflammation [15] . Common risk factors for both asthma and COPD include outdoor air pollution and occupational exposures [16] [17] [18] [19] , though cigarette smoking continues to be the most well-described, modifiable risk factor for COPD [20] . A history of asthma itself has been associated with the increased risk of COPD [21] and accelerated lung function decline [22, 23] . In a 20-year follow-up study by Silva et al. [21] , individuals with active asthma were found to be at increased risk of developing symptoms of chronic bronchitis, being diagnosed with emphysema, and fulfilling criteria consistent with COPD than were individuals with inactive asthma or no asthma history, even after adjustment for age, sex, and smoking history. The fact that individuals with active asthma are at increased risk of developing COPD relative to individuals with inactive asthma suggests that asthma control may affect the occurrence of COPD.
Improving our understanding of the burden of COPD among adults diagnosed with asthma may provide insight into the role of asthma control in the observed overlap between asthma and COPD. We conducted these analyses to examine the prevalence of physician-diagnosed COPD among adults with a history of asthma using data collected routinely for surveillance of asthma in the United States. We report agespecific prevalences of COPD among adult respondents in the Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-back Survey with and without active asthma and across categories of cigarette smoking history.
Methods

Asthma Call-back Survey
We conducted these analyses using data from the 2006-2010 BRFSS adult Asthma Call-back Surveys. The BRFSS is a state-based, random-digit-dial telephone survey of men and women aged 18 years and older conducted annually in the United States [24] . The Asthma Call-back Survey is a follow-up telephone survey conducted approximately two weeks after the BRFSS among respondents who indicated that they have ever had asthma by responding ''yes'' to the following question: ''have you ever been told by a doctor, nurse, or other health professional that you had asthma?'' The BRFSS Asthma Call-back Survey is exempt from Institutional Review Board (IRB) review at the Centers for Disease Control and Prevention; state-specific IRB requirements apply to each of the participating states, the District of Columbia, and Puerto Rico.
Study Sample
We pooled the data collected from BFRSS Asthma Callback Surveys conducted in 2006, 2007, 2008, 2009 [25] [26] [27] . Because the Asthma Call-back Survey was not conducted in each geographic area during all 5 years, this analysis includes 22 geographic areas for which 5 years of data were available (Arizona, California, Connecticut, District of Columbia, Georgia, Hawaii, Indiana, Iowa, Kansas, Maine, Maryland, Massachusetts, Michigan, Montana, Nebraska, New Hampshire, New York, Oregon, Texas, Vermont, Washington, and Wisconsin), 9 states for which 4 years of data were available (Florida, Illinois, Missouri, Nevada, New Mexico, Ohio, Oklahoma, Utah, and West Virginia), 3 states for which 3 years of data were available (New Jersey, North Dakota, and Rhode Island), 6 geographic areas for which 2 years of data were available (Alaska, Colorado, Louisiana, Pennsylvania, Virginia, and Puerto Rico), and 2 states for which 1 year of data was available (Alabama and Mississippi). Pooling these data resulted in 74,209 respondents; we then excluded respondents who did not provide information about physician-diagnosed COPD status, cigarette smoking status, age, educational attainment, race/ethnicity, or sex, resulting in a sample of 71,639 respondents (Fig. 1) . self-reported, physician-diagnosed COPD Physician-Diagnosed COPD We adhered to existing definitions to identify respondents with self-reported, physician-diagnosed COPD status [2, [28] [29] [30] [31] . Briefly described, the respondents were identified as having self-reported, physician-diagnosed COPD if responses were positive to any of the following three questionnaire items: ''Have you ever been told by a doctor or health professional that you have chronic obstructive lung disease, also known as COPD?''; ''Have you ever been told by a doctor or other health professional that you have emphysema?''; and ''Have you ever been told by a doctor or other health professional that you have chronic bronchitis?'' Self-reported, physician-diagnosed COPD is hereafter referred to as ''physician-diagnosed COPD.'' Identification of Active Asthma Among Adults with a History of Asthma As described above, each Asthma Call-back Survey respondent was selected because of a positive response during BRFSS data collection about having been told by a doctor, nurse, or other health professional that he/she had asthma; thus, all respondents are considered to have a history of physician-diagnosed asthma. As in previous analysis of Asthma Call-back Survey data [32, 33], we categorized respondents as having active asthma if they reported that at least one of the following occurred during the past 12 months: talked to a doctor or other health professional about [his/her] asthma, took asthma medication, or experienced any symptoms of asthma. The remaining respondents, those without active asthma, are hereafter referred to as having inactive asthma. Following our main analysis, we conducted a secondary analysis in which we further restricted the categorization of active asthma to include only those respondents who reported experiencing any symptoms of asthma during the past 12 months.
Other Covariates
Each respondent self-reported his/her age, race/ethnicity, sex, educational attainment, and cigarette smoking status. Each respondent's cigarette smoking status was categorized as current smoker, former smoker, or lifetime nonsmoker.
Statistical Analysis
Before pooling data from 2006-2010, we evaluated variation in the estimated prevalences of the variables of interest across the five survey-year period using the RaoScott Chi-square test, a design-adjusted variation of the goodness-of-fit test for equal proportions [34] . The resulting test statistics for active asthma (V 2 = 3.80, 4 degrees
66, 4 df, p = 0.11), current smoking (V 2 = 1.42, 4 df, p = 0.84), former smoking (V 2 = 6.28, 4 df, p = 0.18), and lifetime nonsmoking (V 2 = 7.28, 4 df, p = 0.12) did not indicate differences at a = 0.05 in the proportion of respondents in each category across the 5-year period; therefore, we pooled the 5 datasets and present characteristics of the pooled 2005-2010 samples and the weighted population estimates.
To generate weighted population estimates, we used adjusted sampling weights that account for BRFSS and Asthma Call-back Survey nonresponse and unequal sampling probabilities. Unadjusted annual sampling weights were provided with the Asthma Call-back Survey data. Because we pooled data collected from 2006 through 2010 and because the number of geographic areas with Asthma Call-back Survey varied from year to year, we adjusted the sampling weights in each geographic area by dividing the unadjusted weight by the number of years for which data were available from that geographic area. We estimated prevalence of physician-diagnosed COPD within categories of age and across strata of active asthma and smoking status. We used linear regression to estimate associations between active asthma status and the prevalence of physician-diagnosed COPD. For this analysis, a single linear regression model was adjusted for age as a continuous variable centered at 44 years, educational attainment, race/ethnicity, sex, smoking status, and an interaction of active asthma status and smoking status. Results are presented as prevalence differences (PD), with 95% confidence intervals (CI), indicating estimated changes in the prevalence of physician-diagnosed COPD on the absolute scale. Estimated changes in prevalence between the populations with active asthma and inactive asthma are shown separately for current smokers, former smokers, and lifetime nonsmokers. All analyses were conducted using procedures for analysis of complex sample survey data in SAS version 9.3 (SAS Institute Inc., Cary, North Carolina, USA). Results based on fewer than 50 unweighted respondents (i.e., percentages based upon a denominator\50) or for which the relative standard error is greater than 30% are not reported or interpreted. Table 1 shows characteristics of the 71,639 Asthma Callback Survey respondents, estimated to represent nearly 26.4 million adults with a history of asthma, including active and inactive asthma. In this population, an estimated 72% were identified as having active asthma and an estimated 29% were identified as having physician-diagnosed COPD. Among those with active asthma, the estimated prevalence of physician-diagnosed COPD was 34.6% (95% CI: 33.7, 35.6); among the remaining 28% with inactive asthma, the estimated prevalence of physician-diagnosed COPD was 14.7% (95% CI: 13.4, 15.9). Among respondents with active and inactive asthma, unadjusted percentage of respondents with physician-diagnosed COPD increased across categories of age; age-specific percentages were consistently highest among current smokers and lowest among lifetime nonsmokers (Fig. 2) . Adjusted associations between respondent characteristics, including active compared to inactive asthma status, and the prevalence of self-reported, physician-diagnosed COPD are shown in Table 2 . Adjusted for age, educational attainment, race/ethnicity, and sex, active asthma was associated with a 26.7% (95% CI: 22.5, 30.9) higher prevalence of physician-diagnosed COPD among current smokers, a 20.6% (95% CI: 18.0, 23.3) higher prevalence among former smokers, and an 8.3% (95% CI: 6.1, 10.5) higher prevalence among lifetime nonsmokers. In this adjusted model, the prevalence of physician-diagnosed COPD was 4.6% (95% CI: 3.0, 6.2) higher among female respondents than among male respondents and PDs decreased monotonically with increasing educational attainment ( Table 2) .
Results
When we restricted our categorization of active asthma to include only those respondents who reported experiencing any symptoms of asthma during the past 12 months, we excluded 5,769 respondents who were previously categorized as having active asthma, but who only reported talking to a doctor or other health care professional about his/her asthma or taking asthma medication during the past 12 months. Following this restriction, relative to inactive asthma, active asthma was associated with a 27.6% (95% CI: 23.3, 31.9) higher prevalence of physician-diagnosed asthma among current smokers, a 21.9% (95% CI: 19.2, 24.7) higher prevalence among former smokers, and an 8.8% (95% CI: 6.7, 11.0) higher prevalence among lifetime nonsmokers (not shown).
Discussion
We analyzed data from the 2006-2010 Asthma Call-back Surveys and found higher prevalences of physiciandiagnosed COPD among adults with active asthma than among adults with inactive asthma. These higher prevalences were observed among current and former smokers as well as lifetime nonsmokers, suggesting an important role a Prevalence differences (with 95% confidence intervals) generated from a single model including all covariates shown in the table b Race/ethnicity is included in the model; however, relative standard errors are greater than 30%; therefore, the results are not shown or interpreted for active asthma in the epidemiology of COPD in each category of smoking status. Our findings complement recent estimates of COPD prevalence (e.g., age-adjusted prevalence: 6.5%; unadjusted prevalence: 6.8%) [2] and extend evidence from prospective, observational studies suggesting that knowledge of asthma history may provide information about the risk of COPD. Specifically, greater annual declines in FEV 1 have been observed among individuals with self-reported asthma than among those without self-reported asthma, including among both smokers and nonsmokers [22] ; greater agerelated declines in FEV 1 have been reported among participants with asthma and among cigarette smokers [23] ; and elevated risks of COPD have been reported among adults with active asthma and among current smokers [21] . Our findings build on this evidence by using public health surveillance data that are collected annually to examine whether the relationship between asthma and physiciandiagnosed COPD can be observed in a large, cross-sectional population-based sample. The use of public health surveillance data has been identified as a priority for advancing the prevention and control of COPD [35] . Analysis of such data sources may provide useful information about modifiable factors (e.g., level of asthma control and smoking status), non-modifiable factors (e.g., age and sex), and other characteristics (e.g., educational attainment) associated with the prevalence of physician-diagnosed COPD.
In these analyses, we identified respondents as having active asthma based on positive responses about having talked to a doctor or other health professional about [his/ her] asthma (estimated prevalence: 51%), taken asthma medication (estimated prevalence: 58%), and experienced any symptoms of asthma (estimated prevalence: 64%) during the past 12 months. When we restricted our categorization of active asthma to include only those respondents who reported experiencing any symptoms of asthma during the past 12 months, the associations between active asthma and the prevalence of COPD were approximately 1% higher than those observed in our main analysis, where the definition of active asthma included talking to a doctor or other health care professional about asthma or taking asthma medication during the past 12 months. The small change following this restriction suggests that the associations observed in all three categories of smoking status are only modestly attenuated by the outcomes of discussions with doctors or other health care providers or asthma medication use during the past 12 months. In these data, just 4% were categorized as having active asthma by only having talked to a doctor or other health professional about asthma during the past 12 months and just 1% were categorized by only having taken asthma medication during the past 12 months. Using these public health surveillance data, we were unable to identify whether symptoms reported during the past 12 months improved following discussions with doctors or health professionals or use of medications for asthma, among individuals who reported these factors. Additional analyses conducted among populations responding to similar questions at intervals longer than 12 months apart may provide useful data about the contributing roles of health care visits and asthma medications in defining active asthma. Similarly, additional analyses conducted in the Asthma Call-back Survey or other surveillance data may further improve our understanding of how changes in medications and treatment practices, advances in patient education and self-management methods, and trends in second-hand smoke exposures and cigarette smoking may affect the relationship between asthma and COPD.
We analyzed cross-sectional data and do not have indepth information about factors that may be involved in the development of asthma, COPD, or both. Indeed, because we analyzed surveillance data, we cannot draw conclusions about or contribute to the discussion of whether there exists a causal relationship between asthma and COPD. A major limitation of these data is the lack of information about the extent to which asthma or COPD may have been incorrectly diagnosed or reported; neither the BRFSS nor the Asthma Call-back Survey include means by which the responses may be validated. A comparison of self-reported asthma to asthma classification based on physiologic measures during a clinical exam 10 years earlier has shown that the validity of self-reported asthma varies with asthma severity [36, 37] . In the absence of clinical measures of asthma, participants in survey research are often asked whether they have been told by a doctor, nurse, or other health care provider that they have asthma. Data collected via self-administered questionnaire can be a reliable source of information about asthma [38] ; the extent to which validity and reliability of asthma history information collected via interviewer-administered telephone survey are different from validity and reliability of the same information collected via self-administered questionnaire is unknown. Comparable data evaluating the validity and reliability of physician-reported COPD or the magnitude of recall bias affecting self-report of physician-diagnosed COPD are also unavailable. We reiterate that in these data, self-reported, physician-diagnosed COPD status is considered a proxy for actual disease status. Similarly, selfreported smoking status is considered a proxy for actual smoking status and additional description of current and former smoking habits, such as pack-years of cigarettes smoked, is not available in these data. Information about self-reported smoking status cannot be used to make inferences about the extent to which the prevalence of physician-diagnosed COPD varies within groups, such as among occasional smokers, smokeless-tobacco users, individuals exposed to secondhand tobacco smoke, and those who quit smoking recently versus those who quit long ago, or across categories of pack-years of smoking history.
The large size of the pooled annual survey samples allowed us to evaluate the prevalence of physician-diagnosed COPD within strata of smoking status. We examined an alternate statistical method to adjust sampling weights; revising our analyses with alternate weights, computed by multiplying the proportion of respondents in each survey year by the corresponding survey year's weight, as in previous analyses of Asthma Call-back Survey data [39, 40] , did not markedly affect our results or conclusions (data not shown). Pooling data collected over five years provided a sufficiently large sample to enable us to evaluate the prevalence of physician-diagnosed COPD in nonsmoking and young adults, where the prevalences of COPD are relatively low, and in the sparsely populated category of current smokers with inactive asthma. Improving our understanding of the influence of active manifestations of asthma, including recent asthma symptoms, on long-term respiratory health may improve our growing understanding of the epidemiology of COPD. Indeed, cigarette smoking continues to be the most well-described, modifiable risk factor for COPD [20] , and smoking prevention efforts continue to be identified as the highest priorities to reduce the onset of new COPD and exacerbation of existing COPD [41] . These findings highlight the importance of appropriate management of asthma among smokers and nonsmokers alike.
